Lantern Pharma Advances AI-Designed Cancer Drug LP-184 After Successful Phase 1a Trial patrickwareing.com/news/lantern-p…

Avetra Launches as Next-Generation CRO Focused on Transparency and Faster Study Starts patrickwareing.com/news/avetra-la…

Triana Secures $120M Series B to Advance Novel Glue Degrader into Clinical Trials patrickwareing.com/news/triana-se…

Medtronic’s Hugo Surgical Robot Secures US Clearance patrickwareing.com/news/medtronic…

Pharvaris Reports Positive Phase 3 Results for Oral Hereditary Angioedema Treatment patrickwareing.com/news/pharvaris…

Paradigm Raises $78M to Transform Clinical Research, Acquires Flatiron’s Oncology Trial Unit patrickwareing.com/news/paradigm-…

AstraZeneca’s Latest Amyloidosis Pact with Neurimmune Could Reach $780M patrickwareing.com/news/astrazene…

Innovent Biologics Announces Closing of Global Strategic Partnership with Takeda patrickwareing.com/news/innovent-…

Mirum Gains Hepatitis D Drug in $620M Buyout of Startup Bluejay patrickwareing.com/news/mirum-gai…

Wave and Structure Therapeutics Stocks Double After Obesity Drug Data Readouts patrickwareing.com/news/wave-and-…

SeaBeLife Enters Joint Development Agreement with Unither Pharmaceuticals for Topical Ophthalmic SBL03 patrickwareing.com/news/seabelife…

Dr. Reddy’s Signs $370M Licensing Deal for Immutep’s LAG‑3 Immunotherapy Eftilagimod Alfa patrickwareing.com/news/dr-reddys…

GSK Starts Unwinding Ideaya Alliance, Returning Two Synthetic Lethality Programs patrickwareing.com/news/gsk-start…

Pfizer Signs $1.9B Pact for Fosun Unit’s GLP-1 Drug YP05002 patrickwareing.com/news/pfizer-si…

Abivax Shares Surge Over 20% Amid Rumors of Eli Lilly Acquisition Bid patrickwareing.com/news/abivax-sh…

Scientists Prepare for Clinical Trials of AI-Designed Antibodies, Ushering in a New Era of Drug Discovery patrickwareing.com/news/scientist…

FDA Finalizes Guidance on Biosimilar Promotional Materials, Clarifying Regulatory Expectations patrickwareing.com/news/fda-final…

Teva Moves to Delist 200+ Patents from FDA Orange Book After FTC Challenge patrickwareing.com/news/teva-move…

Formation Bio Makes $605M Play for Lynk’s TYK2 Inhibitor patrickwareing.com/news/formation…

Mayne Pharma Rejects Cosette’s Attempt to Terminate Scheme Deal patrickwareing.com/news/mayne-pha…